Hyperammonemia is a condition in which a person has elevated levels of ammonia. Typical symptoms include irritability, vomiting, confusion, and other effects of swelling in the brain. People of all ...

The individual first received their multiple myeloma (MM) diagnosis in 2019. A new case study details a rare instance of a patient who developed hyperammonemia after achieving complete remission from ...

Higher than normal blood ammonia levels are called hyperammonemia. Acceptable levels depend on age and sex but range from about 42 µg/dL in infants to 200 µg/dL adults assigned male at birth. When you ...

We thank Harold Pupko for raising several relevant points concerning our article.1 Valproate-induced hyperammonemic encephalopathy is a well- described phenomenon, but its precise incidence is unknown ...

Congenital multiple pituitary hormone deficiency (MPHD) is a rare malformation in the midline of the brain, with an incidence of 1 in 100 000 live births. 1 Early diagnosis of MPHD in the absence of ...

The Food and Drug Administration (FDA) has approved a new indication for Carbaglu ® (carglumic acid; Recordati Rare Diseases) for use as adjunctive therapy in the treatment of acute hyperammonemia due ...

Ammonia is a toxic compound produced in the body from the catabolism of amino acids and protein. Hyperammonemia can damage muscle and brain. 1 The body converts ammonia to urea in the liver by means ...

HealthDay News — Severe hyperammonemia, resulting from ammonia that accumulates in stored blood products, should be considered in the setting of cirrhosis, according to a case report published online ...

According to a recent Future Market Insights analysis, the global hyperammonemia treatment market is anticipated to reach a valuation of US$ 1,318.05 Million in 2023 and US$ 2,100 Million by 2033, ...

ZURICH--(BUSINESS WIRE)--Versantis AG, a clinical-stage company developing novel therapies for rare liver diseases and rare pediatric diseases, today announced that the U.S. Food and Drug ...

Saleh Alqahtani and colleagues have provided a welcome reminder that hyperammonemia is a common side effect of valproate therapy.1 However, I am not convinced that hyperammonemia is a benign ...